| 项目编号 |
PRJCA038426 |
| 项目标题 |
SCLC_immunology |
| 涉及领域 |
Medical |
| 数据类型 |
Exome
Transcriptome or Gene expression
|
| 物种名称 |
Homo sapiens
|
| 描述信息 |
Efficacy and safety study of SCLC immunotherapy and accompanying biomarker study |
| 样品范围 |
Multiisolate |
| 发布日期 |
2025-06-23 |
| 出版信息 |
| PubMed ID |
文章标题 |
杂志名称 |
Doi |
发表年份 |
|
|
Harnessing local and system immune profiling delineating differential responders to first-line sintilimab (anti-PD-1 antibody) combined with chemotherapy in extensive …
|
Signal Transduction and Targeted Therapy
|
10.1038/s41392-025-02252-5
|
2025
|
| 40404633
|
Harnessing local and system immune profiling delineating differential responders to first-line sintilimab (anti-PD-1 antibody) combined with chemotherapy in extensive-stage small cell lung cancer: an exploratory biomarker analysis of a phase II study
|
Signal Transduction and Targeted Therapy
|
10.1038/s41392-025-02252-5
|
2025
|
|
|
| 项目资金来源 |
| 机构 |
项目类型 |
授权项目ID |
授权项目名称 |
| Clinical Research Foundation Shanghai Pulmonary Hospital
|
General Program
|
FKLY20013
|
|
| National Key R&D Program of China
|
General Program
|
2023YFC2508600
|
|
| National Key R&D Program of China
|
General Program
|
2023YFC2508601
|
|
| National Key R&D Program of China
|
General Program
|
2023YFC2508603
|
|
| National Key R&D Program of China
|
General Program
|
2023YFC2508604
|
|
|
|
| 提交者 |
Chunxia
Su (susu_mail@126.com)
|
| 提交单位 |
Shanghai Pulmonary Hospital |
| 提交日期 |
2025-04-09 |
